Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIOngoingD-0523-2026

Drug recall · May 13, 2026

NAPROXEN ORAL SUSPENSION recall

Why: Chemical contamination; presence of lead and lithium above specification

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

NAPROXEN ORAL SUSPENSION, USP, 125 mg/5mL, Rx only, 16fl oz (473 mL) bottles, Distributed by: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, Made in Canada NDC 42192-619-16

Lots / codes

Lot: 23F02, Expires: 05/2026; 25A37, Expires: 01/2028.

Quantity
6,336 bottles
Company
Acella Pharmaceuticals, LLC, Alpharetta, GA
Distribution
Nationwide
Initiated
April 20, 2026 · Voluntary: Firm initiated
Classified
May 6, 2026
Reported
May 13, 2026
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Naproxen

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.